The Board of Directors of CSPC Pharmaceutical Group Limited announced that Ms. Wu Guizhen has been appointed as an independent non-executive director of the Company with effect from 27 May 2022. Ms. Wu, aged 62, is the Chief Expert of Biosafety of the Chinese Center for Disease Control and Prevention.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.6 HKD | +1.23% | +12.63% | -9.09% |
Apr. 24 | CSPC Pharmaceutical's EBT Buys 8.5 Million Shares | MT |
Apr. 19 | CSPC Pharmaceutical Group Limited and CSPC Holdings Company Limited Enter into Master Sales Agreement | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.09% | 9.86B | |
+26.18% | 653B | |
+27.00% | 556B | |
-6.61% | 354B | |
+20.97% | 331B | |
+2.43% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-5.94% | 144B |
- Stock Market
- Equities
- 1093 Stock
- News CSPC Pharmaceutical Group Ltd.
- CSPC Pharmaceutical Group Limited Announces Appointment of Wu Guizhen as Independent Non-Executive Director